Citation: Th. Rea, Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy, INT J LEPR, 68(2), 2000, pp. 129-135
Authors:
Yamauchi, PS
Bleharski, JR
Uyemura, K
Kim, J
Sieling, PA
Miller, A
Brightbill, H
Schlienger, K
Rea, TH
Modlin, RL
Citation: Ps. Yamauchi et al., A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosy, J IMMUNOL, 165(3), 2000, pp. 1506-1512
Authors:
Sieling, PA
Ochoa, MT
Jullien, D
Leslie, DS
Sabet, S
Rosat, JP
Burdick, AE
Rea, TH
Brenner, MB
Porcelli, SA
Modlin, RL
Citation: Pa. Sieling et al., Evidence for human CD4(+) T cells in the CD1-restricted repertoire: Derivation of mycobacteria-reactive T cells from leprosy lesions, J IMMUNOL, 164(9), 2000, pp. 4790-4796
Authors:
Sieling, PA
Jullien, D
Dahlem, M
Tedder, TF
Rea, TH
Modlin, RL
Porcelli, SA
Citation: Pa. Sieling et al., CD1 expression by dendritic cells in human leprosy lesions: Correlation with effective host immunity, J IMMUNOL, 162(3), 1999, pp. 1851-1858
Authors:
Garcia, VE
Uyemura, K
Sieling, PA
Ochoa, MT
Morita, CT
Okamura, H
Kurimoto, M
Rea, TH
Modlin, RL
Citation: Ve. Garcia et al., IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection, J IMMUNOL, 162(10), 1999, pp. 6114-6121